Poster 21
- Jun 14, 2023
- 1 min read
Long-Term Disease Control and Safety With Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis Following Failure of Prior Topical Therapies: Results From the TRuE-AD4 Phase 3b Study
Andreas Wollenberg, MD, PhD, H. Chih-ho Hong, MD, Elaine Agius, MD, PhD, Nina Magnolo, MD, Ketty Peris, MD, PhD, Eingun James Song, MD, Sébastien Barbarot, MD, PhD, Konstantin Popovic, PhD, Brett Angel, MD, Qian Li, PhD, José Manuel Carrascosa, MD, PhD
